Annual Accounts Payable
$2.03 M
-$939.00 K-31.62%
December 1, 2023
Summary
- As of February 10, 2025, KNTE annual accounts payable is $2.03 million, with the most recent change of -$939.00 thousand (-31.62%) on December 1, 2023.
- During the last 3 years, KNTE annual accounts payable has fallen by -$1.91 million (-48.45%).
Performance
KNTE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$2.03 M
-$898.00 K-30.66%
December 1, 2023
Summary
- As of February 10, 2025, KNTE quarterly accounts payable is $2.03 million, with the most recent change of -$898.00 thousand (-30.66%) on December 1, 2023.
- Over the past year, KNTE quarterly accounts payable has dropped by -$898.00 thousand (-30.66%).
Performance
KNTE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KNTE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.6% | -30.7% |
| 3 y3 years | -48.5% | -30.7% |
| 5 y5 years | +359.5% | -30.7% |
KNTE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | at low | -54.4% | -0.7% |
| 5 y | 5-year | -48.5% | -52.9% | -54.4% | -52.9% |
| alltime | all time | -48.5% | -78.2% | -54.4% | -52.9% |
Kinnate Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.03 M(-31.6%) | $2.03 M(-30.7%) |
| Sep 2023 | - | $2.93 M(+8.6%) |
| Jun 2023 | - | $2.70 M(-39.4%) |
| Mar 2023 | - | $4.45 M(+49.9%) |
| Dec 2022 | $2.97 M(-5.7%) | $2.97 M(-2.9%) |
| Sep 2022 | - | $3.06 M(+51.7%) |
| Jun 2022 | - | $2.02 M(-54.4%) |
| Mar 2022 | - | $4.42 M(+40.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $3.15 M(-20.1%) | $3.15 M(+15.6%) |
| Sep 2021 | - | $2.72 M(+104.2%) |
| Jun 2021 | - | $1.33 M(-58.5%) |
| Mar 2021 | - | $3.21 M(-18.5%) |
| Dec 2020 | $3.94 M(+312.1%) | $3.94 M(+69.2%) |
| Sep 2020 | - | $2.33 M(+143.5%) |
| Dec 2019 | $956.00 K(+116.3%) | $956.00 K |
| Dec 2018 | $442.00 K | - |
FAQ
- What is Kinnate Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Kinnate Biopharma?
- What is Kinnate Biopharma annual accounts payable year-on-year change?
- What is Kinnate Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kinnate Biopharma?
- What is Kinnate Biopharma quarterly accounts payable year-on-year change?
What is Kinnate Biopharma annual accounts payable?
The current annual accounts payable of KNTE is $2.03 M
What is the all time high annual accounts payable for Kinnate Biopharma?
Kinnate Biopharma all-time high annual accounts payable is $3.94 M
What is Kinnate Biopharma annual accounts payable year-on-year change?
Over the past year, KNTE annual accounts payable has changed by -$939.00 K (-31.62%)
What is Kinnate Biopharma quarterly accounts payable?
The current quarterly accounts payable of KNTE is $2.03 M
What is the all time high quarterly accounts payable for Kinnate Biopharma?
Kinnate Biopharma all-time high quarterly accounts payable is $4.45 M
What is Kinnate Biopharma quarterly accounts payable year-on-year change?
Over the past year, KNTE quarterly accounts payable has changed by -$898.00 K (-30.66%)